Off-Label Use of Gabapentinoids in Non-diabetic Patients Referred to a Rheumatology Clinic: A Cross-Sectional Study
Cureus · 29.03.2026
DOI: 10.7759/cureus.106080 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Cureus, erschienen am 29.03.2026. Verfasst von Gowri Renganathan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Texas Tech University Health Sciences Center El Paso Paul L. Foster School of Medicine, El Paso, USA. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Texas Tech University Health Sciences Center El Paso Paul L. Foster School of Medicine, El Paso, USA.
- Department of Internal Medicine, University Medical Center of El Paso, El Paso, USA.
- Department of Internal Medicine, University of Texas Health Science Center at San Antonio, San Antonio, USA.
- Department of Internal Medicine, Institute of Medicine, Tribhuvan University, Kathmandu, NPL.
Zitieren
APA
Renganathan, G., Alhariri, S., Gutierrez, J., Pathak, N., & Sairam, S. (2026). Off-Label Use of Gabapentinoids in Non-diabetic Patients Referred to a Rheumatology Clinic: A Cross-Sectional Study. Cureus. https://doi.org/10.7759/cureus.106080
Vancouver
Renganathan G, Alhariri S, Gutierrez J, Pathak N, Sairam S. Off-Label Use of Gabapentinoids in Non-diabetic Patients Referred to a Rheumatology Clinic: A Cross-Sectional Study. Cureus. 2026. doi:10.7759/cureus.106080
BibTeX
@article{Renganathan2026,
author = {Renganathan, Gowri and Alhariri, Sara and Gutierrez, Jesus and Pathak, Nibesh and Sairam, Shrilekha},
title = {Off-Label Use of Gabapentinoids in Non-diabetic Patients Referred to a Rheumatology Clinic: A Cross-Sectional Study},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.106080}
}
EUVIMED